Citi analyst Patrick Donnelly added a “90-day positive catalyst watch” on shares of Agilent (A) while keeping a Buy rating on the name with a $165 price target At a time when investor sentiment on tools is negative, the higher end of the Agilent’s fiscal Q2 growth guidance is achievable and its fiscal year numbers “are safe,” the analyst tells investors in a research note. Citi is encouraged by Agilent’s order book.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent, Seagate, Dollar Tree, Coupang, Appian: Insider Moves Unveiled
- Agilent xCELLigence RTCA instrumentation applied in recent FDA approval
- Best Buy, Las Vegas Sands, Globalstar, Opko Health, Agilent: Stock Moves Unveiled
- Agilent’s PD-L1 IHC 28-8 pharmDx gets added indications under EU IVDR1 for NSLC
- Insider Sales Shake Up Analog, Stag, Match, NuScale, Agilent
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue